About Ingevity (NYSE:NGVT)
Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells wood-based chemically activated carbon products primarily for gasoline vapor emission control systems. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the Kraft pulping process. This segment's products are used in various applications comprising asphalt paving, oilfield exploration and production, printing inks, adhesives, agrochemical dispersants, lubricants, and other diverse industries. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina.
Industry, Sector and Symbol
Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSE:NGVT
CUSIPN/A
Phone843-740-2300
Debt
Debt-to-Equity Ratio1.60%
Current Ratio2.41%
Quick Ratio1.36%
Price-To-Earnings
Trailing P/E Ratio30.62
Forward P/E Ratio23.65
P/E Growth1.95
Sales & Book Value
Annual Sales$972.40 million
Price / Sales3.42
Cash Flow$3.5986 per share
Price / Cash21.95
Book Value$6.60 per share
Price / Book11.97
Profitability
EPS (Most Recent Fiscal Year)$2.58
Net Income$126.50 million
Net Margins12.99%
Return on Equity50.74%
Return on Assets12.30%
Miscellaneous
Employees1,500
Outstanding Shares42,080,000
Ingevity (NYSE:NGVT) Frequently Asked Questions
What is Ingevity's stock symbol?
Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."
How were Ingevity's earnings last quarter?
Ingevity (NYSE:NGVT) posted its earnings results on Tuesday, February, 20th. The company reported $0.45 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.36 by $0.09. The firm had revenue of $229.50 million for the quarter, compared to analyst estimates of $214.94 million. Ingevity had a return on equity of 50.74% and a net margin of 12.99%. The company's revenue for the quarter was up 8.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.34 earnings per share. View Ingevity's Earnings History.
When is Ingevity's next earnings date?
What price target have analysts set for NGVT?
7 Wall Street analysts have issued twelve-month target prices for Ingevity's shares. Their forecasts range from $67.00 to $92.00. On average, they anticipate Ingevity's share price to reach $85.7143 in the next year. View Analyst Ratings for Ingevity.
Who are some of Ingevity's key competitors?
Some companies that are related to Ingevity include FMC (FMC), The Chemours (CC), Johnson Matthey (JMPLY), Huntsman (HUN), Olin (OLN), W. R. Grace and (GRA), Ashland (ASH), Univar (UNVR), Balchem (BCPC), GCP Applied Technologies (GCP), PQ Group (PQG), Innospec (IOSP), KMG Chemicals (KMG), Nexeo Solutions (NXEO) and OCI Partners (OCIP).
Who are Ingevity's key executives?
Ingevity's management team includes the folowing people:
- Mr. D. Michael Wilson, Pres, CEO & Director (Age 55)
- Mr. John C. Fortson, Exec. VP, CFO & Treasurer (Age 51)
- Ms. Katherine Pryor Burgeson, Exec. VP, Gen. Counsel & Sec. (Age 60)
- Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 52)
- Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 57)
Has Ingevity been receiving favorable news coverage?
News headlines about NGVT stock have trended somewhat positive recently, according to Accern. The research firm identifies positive and negative press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Ingevity earned a coverage optimism score of 0.11 on Accern's scale. They also gave headlines about the company an impact score of 46.42 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.
How do I buy shares of Ingevity?
Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Ingevity's stock price today?
One share of NGVT stock can currently be purchased for approximately $78.99.
How big of a company is Ingevity?
Ingevity has a market capitalization of $3.30 billion and generates $972.40 million in revenue each year. The company earns $126.50 million in net income (profit) each year or $2.58 on an earnings per share basis. Ingevity employs 1,500 workers across the globe.
How can I contact Ingevity?
Ingevity's mailing address is 5255 VIRGINIA AVENUE, NORTH CHARLESTON SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected]
MarketBeat Community Rating for Ingevity (NGVT)
MarketBeat's community ratings are surveys of what our community members think about Ingevity and other stocks. Vote "Outperform" if you believe NGVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NGVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
Ingevity (NYSE:NGVT) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
7 Wall Street analysts have issued ratings and price targets for Ingevity in the last 12 months. Their average twelve-month price target is $85.7143, suggesting that the stock has a possible upside of 8.51%. The high price target for NGVT is $92.00 and the low price target for NGVT is $67.00. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.86 | 2.86 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $85.7143 | $85.7143 | $79.20 | $69.80 |
| Price Target Upside: | 8.51% upside | 10.56% upside | 11.63% upside | 0.22% upside |
Ingevity (NYSE:NGVT) Consensus Price Target History
Ingevity (NYSE:NGVT) Analyst Ratings History
Show:
(Data available from 4/26/2016 forward)
Ingevity (NYSE:NGVT) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Ingevity (NYSE NGVT) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 0.18%
Institutional Ownership Percentage: 92.37%
Ingevity (NYSE NGVT) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 5/15/2017 | Jean S Blackwell | Director | Buy | 1,500 | $58.38 | $87,570.00 | 4,711 |  |
(Data available from 1/1/2013 forward)
Ingevity (NYSE NGVT) News Headlines
| Source: |
|
Ingevity (NYSE:NGVT) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Ingevity (NYSE:NGVT) Income Statement, Balance Sheet and Cash Flow Statement
Ingevity (NYSE NGVT) Stock Chart for Thursday, April, 26, 2018
Loading chart…
